Related Experiment Videos
Does hyperuricosuria play a role in calcium oxalate lithiasis?
1Department of Internal Medicine, Kaiser Permanente Medical Center, San Francisco, California.
The Journal of Urology
|March 1, 1989
Summary
Elevated urinary uric acid may contribute to calcium oxalate stones. Allopurinol reduces stone recurrence in specific patients with hyperuricosuria, suggesting a link between uric acid and calcium oxalate calculus formation.
Area of Science:
- Nephrology
- Urology
- Biochemistry
Background:
- Calcium oxalate calculi are the most common type of kidney stones.
- The role of urinary uric acid in calcium oxalate stone formation is debated.
- Hyperuricosuria, high levels of uric acid in urine, is a potential risk factor.
Purpose of the Study:
- To review evidence linking urinary uric acid to calcium oxalate calculi.
- To assess the efficacy of allopurinol in preventing stone recurrence.
- To explore the interaction between uric acid and calcium oxalate.
Main Methods:
- Review of epidemiologic, clinical, and experimental studies.
- Analysis of clinical trials involving allopurinol treatment.
- Focus on patient subgroups with isolated hyperuricosuria.
Main Results:
- Epidemiologic and laboratory data show equivocal support for a link.
- Clinical trials demonstrate allopurinol reduces calculus recurrence in specific patients.
- Beneficial effects of allopurinol are seen in patients with calcium oxalate calculi and isolated hyperuricosuria.
Conclusions:
- A specific interaction between uric acid and calcium oxalate in stone formation is suggested.
- Allopurinol is effective in preventing recurrence in a targeted patient group.
- The precise mechanisms underlying this interaction require further investigation.